Literature DB >> 21391235

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

Alexis Elbaz1, Owen A Ross, John P A Ioannidis, Alexandra I Soto-Ortolaza, Frédéric Moisan, Jan Aasly, Grazia Annesi, Maria Bozi, Laura Brighina, Marie-Christine Chartier-Harlin, Alain Destée, Carlo Ferrarese, Alessandro Ferraris, J Mark Gibson, Suzana Gispert, Georgios M Hadjigeorgiou, Barbara Jasinska-Myga, Christine Klein, Rejko Krüger, Jean-Charles Lambert, Katja Lohmann, Simone van de Loo, Marie-Anne Loriot, Timothy Lynch, George D Mellick, Eugénie Mutez, Christer Nilsson, Grzegorz Opala, Andreas Puschmann, Aldo Quattrone, Manu Sharma, Peter A Silburn, Leonidas Stefanis, Ryan J Uitti, Enza Maria Valente, Carles Vilariño-Güell, Karin Wirdefeldt, Zbigniew K Wszolek, Georgia Xiromerisiou, Demetrius M Maraganore, Matthew J Farrer.   

Abstract

OBJECTIVE: We studied the independent and joint effects of the genes encoding alpha-synuclein (SNCA) and microtubule-associated protein tau (MAPT) in Parkinson disease (PD) as part of a large meta-analysis of individual data from case-control studies participating in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) consortium.
METHODS: Participants of Caucasian ancestry were genotyped for a total of 4 SNCA (rs2583988, rs181489, rs356219, rs11931074) and 2 MAPT (rs1052553, rs242557) single nucleotide polymorphism (SNPs). Individual and joint effects of SNCA and MAPT SNPs were investigated using fixed- and random-effects logistic regression models. Interactions were studied on both a multiplicative and an additive scale, and using a case-control and case-only approach.
RESULTS: Fifteen GEO-PD sites contributed a total of 5,302 cases and 4,161 controls. All 4 SNCA SNPs and the MAPT H1-haplotype-defining SNP (rs1052553) displayed a highly significant marginal association with PD at the significance level adjusted for multiple comparisons. For SNCA, the strongest associations were observed for SNPs located at the 3' end of the gene. There was no evidence of statistical interaction between any of the 4 SNCA SNPs and rs1052553 or rs242557, neither on the multiplicative nor on the additive scale.
INTERPRETATION: This study confirms the association between PD and both SNCA SNPs and the H1 MAPT haplotype. It shows, based on a variety of approaches, that the joint action of variants in these 2 loci is consistent with independent effects of the genes without additional interacting effects.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21391235      PMCID: PMC3082599          DOI: 10.1002/ana.22321

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  45 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  A method for meta-analysis of case-control genetic association studies using logistic regression.

Authors:  Pantelis G Bagos; Georgios K Nikolopoulos
Journal:  Stat Appl Genet Mol Biol       Date:  2007-06-14

3.  Synergy and antagonism in cause-effect relationships.

Authors:  K J Rothman
Journal:  Am J Epidemiol       Date:  1974-06       Impact factor: 4.897

4.  The design of case-control studies: the influence of confounding and interaction effects.

Authors:  P G Smith; N E Day
Journal:  Int J Epidemiol       Date:  1984-09       Impact factor: 7.196

5.  Concepts of interaction.

Authors:  K J Rothman; S Greenland; A M Walker
Journal:  Am J Epidemiol       Date:  1980-10       Impact factor: 4.897

6.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

7.  Genomic investigation of alpha-synuclein multiplication and parkinsonism.

Authors:  Owen A Ross; Adam T Braithwaite; Lisa M Skipper; Jennifer Kachergus; Mary M Hulihan; Frank A Middleton; Kenya Nishioka; Julia Fuchs; Thomas Gasser; Demetrius M Maraganore; Charles H Adler; Lydie Larvor; Marie-Christine Chartier-Harlin; Christer Nilsson; J William Langston; Katrina Gwinn; Nobutaka Hattori; Matthew J Farrer
Journal:  Ann Neurol       Date:  2008-06       Impact factor: 10.422

8.  Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.

Authors:  John E Duda; Benoit I Giasson; Meghann E Mabon; Douglas C Miller; Lawrence I Golbe; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2002-04-27       Impact factor: 17.088

9.  Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.

Authors:  Owen A Ross; David Gosal; Jeremy T Stone; Sarah J Lincoln; Michael G Heckman; G Brent Irvine; Janet A Johnston; J Mark Gibson; Matthew J Farrer; Timothy Lynch
Journal:  Mech Ageing Dev       Date:  2007-04-24       Impact factor: 5.432

10.  Tau gene and Parkinson's disease: a case-control study and meta-analysis.

Authors:  D G Healy; P M Abou-Sleiman; A J Lees; J P Casas; N Quinn; K Bhatia; A D Hingorani; N W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

View more
  44 in total

1.  In search of the causes of Parkinson's disease, seasons 1 to 4.

Authors:  Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-05-31       Impact factor: 8.082

Review 2.  Alzheimer's disease pathologic cascades: who comes first, what drives what.

Authors:  Russell H Swerdlow
Journal:  Neurotox Res       Date:  2011-09-13       Impact factor: 3.911

3.  Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.

Authors:  Lisa Wang; Michael G Heckman; Jan O Aasly; Grazia Annesi; Maria Bozi; Sun Ju Chung; Carl Clarke; David Crosiers; Gertrud Eckstein; Gaetan Garraux; Georgios M Hadjigeorgiou; Nobu Hattori; Beom Jeon; Yun J Kim; Masato Kubo; Suzanne Lesage; Juei Jueng Lin; Timothy Lynch; Peter Lichtner; George D Mellick; Vincent Mok; Karin E Morrison; Aldo Quattrone; Wataru Satake; Peter A Silburn; Leonidas Stefanis; Joanne D Stockton; Eng King Tan; Tatsushi Toda; Alexis Brice; Christine Van Broeckhoven; Ryan J Uitti; Karin Wirdefeldt; Zbigniew Wszolek; Georgia Xiromerisiou; Demetrius M Maraganore; Thomas Gasser; Rejko Krüger; Matthew J Farrer; Owen A Ross; Manu Sharma
Journal:  Neurobiol Aging       Date:  2016-10-06       Impact factor: 4.673

4.  Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study.

Authors:  Lisa F Potts; Alex C Cambon; Owen A Ross; Rosa Rademakers; Dennis W Dickson; Ryan J Uitti; Zbigniew K Wszolek; Shesh N Rai; Matthew J Farrer; David W Hein; Irene Litvan
Journal:  BMC Med Genet       Date:  2012-03-17       Impact factor: 2.103

Review 5.  Genetic variability in SNCA and Parkinson's disease.

Authors:  Lasse Pihlstrøm; Mathias Toft
Journal:  Neurogenetics       Date:  2011-07-29       Impact factor: 2.660

6.  GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16.

Authors:  Alexandra I Soto-Ortolaza; Michael G Heckman; Catherine Labbé; Daniel J Serie; Andreas Puschmann; Sruti Rayaprolu; Audrey Strongosky; Magdalena Boczarska-Jedynak; Grzegorz Opala; Anna Krygowska-Wajs; Maria Barcikowska; Krzysztof Czyzewski; Timothy Lynch; Ryan J Uitti; Zbigniew K Wszolek; Owen A Ross
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

7.  DNAJC13 mutations in Parkinson disease.

Authors:  Carles Vilariño-Güell; Alex Rajput; Austen J Milnerwood; Brinda Shah; Chelsea Szu-Tu; Joanne Trinh; Irene Yu; Mary Encarnacion; Lise N Munsie; Lucia Tapia; Emil K Gustavsson; Patrick Chou; Igor Tatarnikov; Daniel M Evans; Frederick T Pishotta; Mattia Volta; Dayne Beccano-Kelly; Christina Thompson; Michelle K Lin; Holly E Sherman; Heather J Han; Bruce L Guenther; Wyeth W Wasserman; Virginie Bernard; Colin J Ross; Silke Appel-Cresswell; A Jon Stoessl; Christopher A Robinson; Dennis W Dickson; Owen A Ross; Zbigniew K Wszolek; Jan O Aasly; Ruey-Meei Wu; Faycal Hentati; Rachel A Gibson; Peter S McPherson; Martine Girard; Michele Rajput; Ali H Rajput; Matthew J Farrer
Journal:  Hum Mol Genet       Date:  2013-11-11       Impact factor: 6.150

Review 8.  Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.

Authors:  Xuling Li; Simon James; Peng Lei
Journal:  J Mol Neurosci       Date:  2016-09-15       Impact factor: 3.444

9.  MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome.

Authors:  Angela Roco; Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Elena García-Martín; José A G Agúndez
Journal:  J Neural Transm (Vienna)       Date:  2012-09-22       Impact factor: 3.575

10.  Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

Authors:  Michael G Heckman; Alexis Elbaz; Alexandra I Soto-Ortolaza; Daniel J Serie; Jan O Aasly; Grazia Annesi; Georg Auburger; Justin A Bacon; Magdalena Boczarska-Jedynak; Maria Bozi; Laura Brighina; Marie-Christine Chartier-Harlin; Efthimios Dardiotis; Alain Destée; Carlo Ferrarese; Alessandro Ferraris; Brian Fiske; Suzana Gispert; Georgios M Hadjigeorgiou; Nobutaka Hattori; John P A Ioannidis; Barbara Jasinska-Myga; Beom S Jeon; Yun Joong Kim; Christine Klein; Rejko Kruger; Elli Kyratzi; Chin-Hsien Lin; Katja Lohmann; Marie-Anne Loriot; Timothy Lynch; George D Mellick; Eugénie Mutez; Grzegorz Opala; Sung Sup Park; Simona Petrucci; Aldo Quattrone; Manu Sharma; Peter A Silburn; Young Ho Sohn; Leonidas Stefanis; Vera Tadic; Hiroyuki Tomiyama; Ryan J Uitti; Enza Maria Valente; Demetrios K Vassilatis; Carles Vilariño-Güell; Linda R White; Karin Wirdefeldt; Zbigniew K Wszolek; Ruey-Meei Wu; Georgia Xiromerisiou; Demetrius M Maraganore; Matthew J Farrer; Owen A Ross
Journal:  Neurobiol Aging       Date:  2013-08-17       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.